Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impact of DIO2 polymorphisms on quality of life and TSH suppression therapy in patients with papillary thyroid cancer.

BMC endocrine disorders - 2 Dec 2025

Chen Junhan, Lin Zhiqing, Luo Yezhe, Tang Hui, Chen Fangsen, Liu Peitian, Huang Yanling

Abstract excerpt

BACKGROUND: This study aims to explore the impact of type 2 deiodinase (DIO2) polymorphisms on TSH suppression therapy and quality of life in patients with papillary thyroid cancer. METHODS: A cohort of 200 patients with papillary thyroid cancer was recruited at Zhongshan Hospital, Xiamen University, between September 2021 and September 2022, with 88 in the lobectomy group and 74 in the total thyroidectomy plus...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Iodide Peroxidase
Share to Iodine Radioisotopes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Iodothyronine Deiodinase Type II

Share to Quality of Life

Share to Thyroid Cancer, Papillary

Share to Thyroid Neoplasms

Share to Thyroidectomy

Share to Thyrotropin

Source

Open in PubMed Open full text

Identifiers

PMID: 41331813
DOI: 10.1186/s12902-025-02085-x
PMCID: PMC12673731

Genes

DIO2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impact of DIO2 polymorphisms on quality of life and TSH suppression therapy in patients with papillary thyroid cancer.PMID 41331813Read ↗

Determination of frequency of Type 2 deiodinase Thr92Ala polymorphism (rs225014) in 131I-treated differentiated thyroid cancer patients undertaking L-Thyroxine (L-T4) suppression therapy.Semantic proximity Read ↗

Increased type 3 deiodinase expression in papillary thyroid carcinoma.Semantic proximity Read ↗

The role of type II deiodinase polymorphisms in clinical management of hypothyroid patients treated with levothyroxine.Semantic proximity Read ↗

DIO2 Thr92Ala Reduces Deiodinase-2 Activity and Serum-T3 Levels in Thyroid-Deficient Patients.Semantic proximity Read ↗

SNP rs11185644 in RXRA gene and SNP rs2235544 in DIO1 gene predict dosage requirements in a cross-sectional sample of hypothyroid patients.Semantic proximity Read ↗

A common variation in deiodinase 1 gene DIO1 is associated with the relative levels of free thyroxine and triiodothyronine.Semantic proximity Read ↗

The type 2 deiodinase ORFa-Gly3Asp polymorphism (rs12885300) influences the set point of the hypothalamus-pituitary-thyroid axis in patients treated for differentiated thyroid carcinoma.Semantic proximity Read ↗

Genetic abnormalities in thyroid hormone deiodinases.Semantic proximity Read ↗

The Physiological Functions and Polymorphisms of Type II DeiodinaseSemantic proximity Read ↗

Effect of DIO2 Gene Polymorphism on Thyroid Hormone Levels and Its Correlation with the Severity of Schizophrenia in a Pakistani Population.Semantic proximity Read ↗

Association of DIO2 and MCT10 Polymorphisms With Persistent Symptoms in LT4-Treated Patients in the UK Biobank.Semantic proximity Read ↗

Pretranslational Regulation of Type 2 DeiodinaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.